The Role of Autologous Stem-Cell Transplantation in High-Risk Neuroblastoma Consolidated by anti-GD2 Immunotherapy. Results of Two Consecutive Studies

por Mora, Jaume, Castañeda, Alicia, Flores, Miguel A., Santa-María, Vicente, Garraus, Moira, Gorostegui, Maite, Simao, Margarida, Perez-Jaume, Sara, Mañe, Salvador
Publicado 2020

Novel infusion strategy reduces severe adverse events caused by the anti-GD2 monoclonal antibody naxitamab

por Varo, Amalia, Castañeda, Alicia, Chamorro, Saray, Muñoz, Juan Pablo, Gorostegui, Maite, Celma, Mónica S., Lopez, Sandra, Simao, Margarida, Perez-Jaume, Sara, Mora, Jaume
Publicado 2023

Naxitamab Combined with Granulocyte-Macrophage Colony-Stimulating Factor as Consolidation for High-Risk Neuroblastoma Patients in First Complete Remission under Compassionate Use—U...

por Mora, Jaume, Castañeda, Alicia, Gorostegui, Maite, Varo, Amalia, Perez-Jaume, Sara, Simao, Margarida, Muñoz, Juan Pablo, Garraus, Moira, Larrosa, Cristina, Salvador, Noelia, Lavarino, Cinzia, Krauel, Lucas, Mañe, Salvador
Publicado 2023

Early Salvage Chemo-Immunotherapy with Irinotecan, Temozolomide and Naxitamab Plus GM-CSF (HITS) for Patients with Primary Refractory High-Risk Neuroblastoma Provide the Best Chanc...

por Muñoz, Juan Pablo, Larrosa, Cristina, Chamorro, Saray, Perez-Jaume, Sara, Simao, Margarida, Sanchez-Sierra, Nazaret, Varo, Amalia, Gorostegui, Maite, Castañeda, Alicia, Garraus, Moira, Lopez-Miralles, Sandra, Mora, Jaume
Publicado 2023